Beatrice M.
- Country
- Italy
- Department
- Cardiologia - UTIC
Research Overview
- Evaluation of Heart Rate and Quality of Life in Patients with Transthyretin Cardiac Amyloidosis: The HARLEY Study
- Long-term Safety and Tolerability Evaluation of Aficamten (CK-3773274) in Adults with Symptomatic Hypertrophic Cardiomyopathy: An Open-label Extension Study
- Evaluation of Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy: A Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 89 of 190 partner sites.
Specializations
Cardiomyopathy Research Focus
This investigator specializes in the study of various forms of cardiomyopathy, with particular emphasis on rare and complex cardiac conditions.
- Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Hypertrophic Cardiomyopathy (HCM)
- Non-obstructive Hypertrophic Cardiomyopathy
The research encompasses both obstructive and non-obstructive cardiac conditions.
Treatment Evaluation
The investigator conducts comprehensive evaluations of novel therapeutic agents for cardiac disorders, focusing on:
- Long-term safety assessments
- Treatment efficacy studies
- Patient symptom management
Particular attention is given to cardiovascular clinical events and patient outcomes.
Clinical Expertise
The investigator's clinical focus encompasses therapeutic innovations in cardiology, including:
- Novel cardiac medications
- Exercise capacity assessment
- Patient-reported health outcomes
Research includes evaluation of standard of care protocols and emerging treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.